Science & Tech
After COVID vaccines, time to use mRNA tech against other infectious diseases

After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media

Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.
But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "
There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.
Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.
Strong communities start with opportunity. Bank of America invested nearly $40 million in workforce development programs in 2025 — helping 86,400 people connect to jobs, and 264,000 build new skills that strengthen local economies. Explore how Bank of America is building the workforce of today and tomorrow.
France and Germany have scrapped their $115.6 billion joint fighter jet project, collapsing Europe's most ambitious defense initiative after years of corporate infighting.
300 Iraqi Kurds were captured by Libyan militias in the North African country last summer
The US-Canada relationship has long been one of the closest partnerships in the world, but tensions have emerged since Donald Trump returned to office. The timing is far from ideal: the USMCA trade agreement is up for review in a few weeks.